Publication | Closed Access
Bioequivalence study of two fluconazole capsule formulations in healthy volunteers.
11
Citations
0
References
2004
Year
Since the 90% CI for both Cmax, AUC(last) and AUC(0-inf) were within the 80-125% interval proposed by the Food and Drug Administration, it was concluded that fluconazole 150 mg capsule was bioequivalent to Zoltec 150 mg, according to both the rate and extent of absorption.